Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Jaguar Health, Inc. develops plant-derived prescription medicines targeting gastrointestinal disorders in humans and animals. Its core products include crofelemer-based drugs like Mytesi for HIV-related diarrhea and Canalevia for canine diarrhea. The company focuses on unmet medical needs such as cancer therapy-related diarrhea, rare diseases, and supportive care, leveraging sustainable botanical sources and proprietary formulations to provide first-in-class, natural treatment options globally.
This description was generated via AI from an annual report. Updated about 1 year ago.